Project Number GC-201801-2014589 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2018 View Full Project Details for Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Van Eldik, Linda Principal Investigator First Name Linda Principal Investigator Last Name Van Eldik Awardee Organization University of Kentucky Research Foundation Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement Program to Accelerate Clinical Trials (PACT) RFP FY Overall Cost $1,434,160 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
